• LOGIN
  • CONTACT US
  • enEnglish (English)
    • deDeutsch (German)
    • esEspañol (Spanish)
    • zh-hans简体中文 (Chinese (Simplified))
    • ja日本語 (Japanese)
    • pt-brPortuguês (Portuguese (Brazil))
    • heעברית (Hebrew)
    • ko한국어 (Korean)
    • frFrançais (French)
Arazy Group Consultants Inc.
  • Regulatory Solutions
    • LICENSALE®
    • REGISLATE®
    • Choose Your Regulatory Solution
    • Cost and Savings
    • European Regulatory Representative Services
  • 140 Countries
  • Resources
  • About Us
    • Webinars
    • Careers
Select Page

Thailand Update – 2021

by arazygroup | Nov 30, 2021 | Regulatory Update, Regulatory Update Slider, Videos | 0 comments

Thailand - September 2021 Regulatory Update

Thailand Update – 2021

Welcome to the Arazy Group’s regulatory update. Today’s update is from Thailand. Today we will cover the regulatory updates that were introduced...

Welcome to the Arazy Group’s regulatory update. Today’s update is from Thailand.
Today we will cover the regulatory updates that were introduced in December 2019 but were only enforced on February 15, 2021, for Class 2, 3, and 4 and on March 15 for class 1 devices.
New product classification and grouping, New registration fees and timeline, and new registration procedures.
Let's review each update in detail.

Product risk classification. Before December 2019, medical devices and IVD were classified into 3 risk categories: a general medical device for high-risk products, notified medical device for medium-risk products, and a licensed medical device for low-risk products.
Since February 2021, medical devices and IVDs are classified into 4 risk categories; Class one for low-risk products, Class 2 for low to moderate-risk products, class 3 for moderate to high-risk products, and class 4 for high-risk products.

The new product grouping will allow all product classification to be grouped as either a family, a system, a set, an IVD test kit, or an IVD cluster. The devices are grouped based on the following criteria:
they have the same generic proprietary and/or product name, they are sold under a single brand name (meant to be used together as a system), they are intended to be used in combination to achieve a common intended purpose, they are all under the same legal manufacturer, and they are compatible when used together as a system.

If you are looking to register your products in Thailand, consider LICENSALE, our Global MedTech Registration system for fast, and easy market access.

The fees for the registration have increased almost 3 times from previous fees for all product classifications. The review and registration timeline remains the same for classes 2, 3, and 4, and is extended for class 1 devices from a maximum of 60 days to 200 days.
In the old registration procedure, there were 2 registration pathways; For general medical devices, the applicant was only required to conduct CFS verification. While for notified and licensed medical devices, the applicant was required to submit a hard copy of the full dossier manually to the Thai FDA.
In the new registration, there is only 1 registration pathway for all product classification. This new pathway consists of 2 stages, pre-submission, and submission.

All applications are to be made through an online registration system. In the Pre-submission stage, the authority verifies the product risk classification and grouping. In the Submission stage, the authority reviews the technical documents.
Starting Feb 15, 2021, the Thai FDA provided 3 years to implement the new regulatory system. Thai FDA introduced transitional registration schemes: Partial registration and full registration. All existing registered products must be re-registered with the Thai FDA using the Partial Registration Scheme. Under this scheme, some compliance documentation (CSDT) will be waived. However, all new products must undergo full Registration, where complete technical documentation (CSDT) is required.

That’s our update for today. If you have any comments or questions please do not hesitate to email or call us. Check the contact us page on our website for an Arazy Group office near you. Follow Arazy Group on Linkedin to view other countries' regulatory updates, as well as the latest advancements in regulatory affairs technology. Stay safe and keep well.

D

Search

Recent Posts

  • Malaysia – July 2022
  • Pakistan – July 2022
  • South Africa – June 2022
  • La Technologie des Dispositifs Médicaux
  • The Philippines- June 2022
  • Singapore- April 2022
  • Indonesia- March 2022
  • Malaysia- march 2022
  • The Philippines- Feb 2022
  • Malaysia Update – January 2022

Recent Comments

    Archives

    Categories

    • Application
    • Blog
    • Case Study
    • Documents
    • Homepage
    • Product Demo
    • Product Demo Slider
    • Products
    • Recent Registrations
    • Regulatory News
    • Regulatory News Slider
    • Regulatory Update
    • Regulatory Update Slider
    • Support
    • Top Story Slider
    • Uncategorized
    • Videos

    Arazy Group Consultants Inc. is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets

    Visit Us On FacebookVisit Us On TwitterVisit Us On Linkedin

    Regulatory Solutions

    • LICENSALE
    • REGISLATE
    • European Regulatory Representative Services
    • Resources
    • Privacy Policy
    • ISO 9001 Certificate

    Head Office

    #200-1333 Johnston St., Granville Island,
    Vancouver, BC V6H 3R9

    PHONE: +1 604.681.6888
    FAX: +1 604.681.6822
    [email protected]

    © Arazy Group Consultants Inc. - is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets
    ???

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Arazy Group Consultants Inc.
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    Security_overview - Privacy Policy